Montara Therapeutics, Inc. is a precision-medicine neuroscience startup based in San Francisco. The company is dedicated to developing safer and more effective therapies for patients with central nervous system (CNS) disorders. With a team of experts from successful biotech firms and a world-class Scientific Advisory Board, Montara Therapeutics brings a fresh approach to tackling challenging established targets, along with unique experience in developing enzyme activators and expertise in mitophagy. Founded in 2023, the company focuses on precision medicine and genetically validated targets to enhance drug safety and efficacy in the biopharma, biotechnology, and health and wellness industries. Montara Therapeutics recently secured an $8.00M Seed Round investment on 30 July 2024, with participation from notable investors including KdT Ventures, Dolby Ventures, Dementia Discovery Fund, and Two Bear Capital.
No recent news or press coverage available for Montara Therapeutics, Inc..